1-4 of 4
Georgina Meneses-Lorente
Close
Sort by
Journal Articles

Influence of Baseline Disease Characteristics and Exposure to Obinutuzumab on Clinical Outcome in Patients with Previously Untreated Advanced Follicular Lymphoma Treated with Obinutuzumab-Based Immunochemotherapy in the GALLIUM Trial

Candice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, Vincent Buchheit, Pauline Baumlin, Denis Sahin, Guillaume Cartron, Robert Marcus, Wolfgang Hiddemann, MD PhD, John F Seymour, MBBS, PhD, Jonathan C Strefford, PhD, Georgina Meneses-Lorente, Nicolas Frey, Günter Fingerle-Rowson
Journal: Blood
Blood (2017) 130 (Supplement 1): 3848.
https://doi.org/10.1182/blood.V130.Suppl_1.3848.3848
Published: 2017
Journal Articles

Greater Efficacy and Potency of Obinutuzumab Compared with Rituximab in Chronic Lymphocytic Leukemia Patients Confirmed By a Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Model

Kubra Kamisoglu, Alex Phipps, Candice Jamois, Vincent Buchheit, Georgina Meneses-Lorente, Günter Fingerle-Rowson, Jonathan Wagg, Donald E Mager
Journal: Blood
Blood (2017) 130 (Supplement 1): 1267.
https://doi.org/10.1182/blood.V130.Suppl_1.1267.1267
Published: 2017
Journal Articles

Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+ Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000),

David Carlile, PhD, Georgina Meneses-Lorente, PhD, Elisabeth Wassner-Fritsch, Florence Hourcade-Potelleret, PhD, Michael K. Wenger, Guillaume Cartron, MD, PhD, Umberto Vitolo, MD, John Radford, MD, Andrew Davies, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3704.
https://doi.org/10.1182/blood.V118.21.3704.3704
Published: 2011
Journal Articles

Pharmacokinetics of RO5072759 (GA101) In Patients with Relapsed/Refractory CD20 + Malignant Disease (Phase I/II Study BO20999)

Georgina Meneses-Lorente, PhD, David Carlile, PhD, Joe Birkett, PhD, Michael K. Wenger, MD, Guillaume Cartron, MD, PhD, Franck Morschhauser, MD, PhD, Gilles Andre Salles, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1833.
https://doi.org/10.1182/blood.V116.21.1833.1833
Published: 2010